Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Greatest existential risk

O’Neil 16[Lord Jim O'Neill, the former chief economist for Goldman Sachs - the United Kingdom's commercial secretary to the Treasury and led the government's Review on Antimicrobial Resistance, Summer 2016, “The Global Threat of Antimicrobial Resistance”, Pew Trusts, https://www.pewtrusts.org/en/trend/archive/summer-2016/the-global-threat-of-antimicrobial-resistance, accessed 6-28-2022]

According to the World Health Organization (WHO), resistance to antibiotics and other types of antimicrobials is growing and represents the single greatest challenge in infectious diseases today. The WHO reported nearly half a million new cases of multidrug-resistant tuberculosis across 100 countries in 2013, amounting to more than 20 percent of previously treatable tuberculosis cases now being resistant to multiple drugs. In the United States, the Centers for Disease Control and Prevention estimates that each year, at least 2 million people become infected with bacteria that are resistant to antibiotics, and at least 23,000 of them die. This inflicts a direct cost of $20 billion on the U.S. health care system. In the agricultural sector, U.S. Food and Drug Administration sales data showed that drugmakers sold more than 20 million pounds of medically important antibiotics for use in food-producing animals in 2014—23 percent more than in 2009—the most ever reported and more than twice the amount of antibiotics sold to treat people.

This is a global health crisis that knows no borders. Left unchecked, antimicrobial resistance (AMR) will touch all people, regardless of their nationality or their country’s level of development. It will dangerously undermine health care as we know it, making common procedures such as cancer chemotherapy or cesarean section births—which depend on effective antibiotics to reduce their risks—far more dangerous than they are today. Indeed, by 2050, 10 million people a year could be dying as a result of AMR, up from around 700,000 today, with China and India each being home to about 1 million affected patients. And by then, an estimated $100 trillion in global GDP will have been lost.

Just as infections travel with the people who carry them, so does resistance, so solving AMR is a shared responsibility. AMR is one of the biggest health threats facing the world, but it is not beyond the world’s ability to meet and conquer it, both economically and scientifically. The global community must act together, and quickly, to address the problem.

Sign in to recut, update, or save this card.